HY 499, and Enterococcus faecalis secrete bacteriocins that inhibit the growth of pathogens, including Staphylococcus epidermidis , Propionibacterium acnes , and Staphylococcus aureus (199201)
The regulatory approval process involved comprehensive Phase III trials including over 20,000 participants, demonstrating consistent therapeutic benefits across diverse patient populations
Tt c cc hnh thc ca Glutathione ung (thuc vin, vin nang, cht lng, bt, liposomal hoc ngm di li) thng c kh nng c dung np liu lng khuyn co l: 500-1000 mg / ngy trong vng 6 thng
It will have a deep, immediate effect on the lives of PA patients and their families
G.MestdaghP.VandesompeleJ.BrusselleG
Cartilage-specific targeting Why cartilage needs support: Cartilage has no blood supply (avascular) Nutrients diffuse slowly from synovial fluid Healing extremely slow (6-12+ months) Degenerates with age and use Poor regenerative capacity naturally Cartilage structure: Chondrocytes: Cartilage cells (only 1-5% of volume) Extracellular matrix: 95-99% of cartilage Collagen Type II (structure) Proteoglycans (water retention, cushioning) Water (65-80% of weight) Provides smooth, low-friction joint surface Absorbs compressive forces Age-related cartilage changes: Chondrocyte activity declines (less matrix production) Collagen degradation exceeds synthesis Water content decreases (less cushioning) Inflammatory markers increase Net result: Joint degeneration How Cartalax targets cartilage: Specific uptake by chondrocytes Gene regulation in cartilage cells Restores cartilage matrix balance Reduces age-related decline Conditions potentially helped: Osteoarthritis (cartilage wear) Age-related joint stiffness Post-injury cartilage damage Athletic overuse Preventive joint maintenance See best peptides for joint pain for comprehensive options
